ID: ALA2385371

Max Phase: Preclinical

Molecular Formula: C25H28N2

Molecular Weight: 356.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(C(c2ccccc2)c2ccccc2)[C@H](Cc2ccccc2)CN1

Standard InChI:  InChI=1S/C25H28N2/c1-20-19-27(24(18-26-20)17-21-11-5-2-6-12-21)25(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-26H,17-19H2,1H3/t20-,24-/m1/s1

Standard InChI Key:  YMPROSRVUQJLNK-HYBUGGRVSA-N

Associated Targets(non-human)

Voltage-gated L-type calcium channel alpha-1C subunit 1321 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Voltage-gated N-type calcium channel alpha-1B subunit 471 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.51Molecular Weight (Monoisotopic): 356.2252AlogP: 4.68#Rotatable Bonds: 5
Polar Surface Area: 15.27Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.69CX LogP: 5.65CX LogD: 3.39
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -0.12

References

1. Borzenko A, Pajouhesh H, Morrison JL, Tringham E, Snutch TP, Schafer LL..  (2013)  Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers.,  23  (11): [PMID:23639535] [10.1016/j.bmcl.2013.03.114]

Source